4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Relay Therapeutics, Inc. (RLAY) operates in the Biotechnology industry and is headquartered in Cambridge, United States with about 193 employees. Its market capitalization is roughly $4 billion. In the fiscal year ended 2025-12-31, RLAY reported $15M in revenue and ($276M) in net income.
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It transforms the drug discovery process with a focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications.
Interactive charts & full statements → Open the RLAY valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $15M | $10M | $26M | $1M | — |
| Operating Income (EBIT) | ($303M) | ($386M) | ($379M) | ($311M) | — |
| Net Income | ($276M) | ($338M) | ($342M) | ($290M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $3M | $7M | $0M | $1M | $8M | — |
| Operating Income (EBIT) | ($79M) | ($61M) | ($80M) | ($77M) | ($85M) | — |
| Net Income | ($73M) | ($55M) | ($74M) | ($70M) | ($77M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $621M | $871M | $844M | $1.1B | — |
| Total Liabilities | $54M | $94M | $92M | $150M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive RLAY viewer.
About TickerBase · Data methodology & sources